Hong Kong stock anomaly | Hengbo pharmaceutical -B (02142.HK) rose more than 4% entered into a global strategic cooperation agreement with Dai Toshi, laying the potential cooperation foundation for the future T-cell connector field.
According to the Securities Times APP, He Bo Pharmaceutical -B (02142.HK) is up more than 4%, as of the time of publication, it is up 4.36% to 8.12 Hong Kong dollars, with a turnover of 9.6416 million Hong Kong dollars.
Latest
